Literature DB >> 3899917

HLA-B27 and clinical aspects of ankylosing spondylitis: results of prospective studies.

P Wagener, W Mau, H Zeidler, G Eckert, M Robin-Winn, H Deicher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3899917     DOI： 10.1111/j.1600-065x.1985.tb01139.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  3 in total

1.  Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 2.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

3.  Outcome of possible ankylosing spondylitis in a 10 years' follow-up study.

Authors:  W Mau; H Zeidler; R Mau; A Majewski; J Freyschmidt; H Deicher
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.